Wolverine Stack Product Brief

Ready-to-Sell Research Product Sheet

1. Stack Overview

The Wolverine Stack refers to the combination of two research peptides: BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4 fragment). 

This stack is widely researched for its potential role in tissue repair, recovery, and regenerative pathways. The combination is commonly explored in research settings focused on injury recovery, connective tissue support, and cellular repair mechanisms.

2. Mechanism of Interest

The Wolverine Stack is studied for potential complementary mechanisms:

• BPC-157 is investigated for angiogenesis and tissue repair pathways
  • TB-500 is studied for cell migration and regeneration processes
  • The combination may support connective tissue recovery research
  • Potential influence on muscle, tendon, and ligament repair mechanisms
  • May support anti-inflammatory signaling pathways

3. Research Areas Being Explored

• Tendon and ligament recovery research
  • Muscle repair and regeneration pathways
  • Joint and connective tissue support
  • Injury recovery models
  • Cellular repair and healing pathways

4. Suggested Product Formats

• BPC-157 5 mg + TB-500 5 mg dual vial kit
  • BPC-157 10 mg + TB-500 10 mg dual vial kit
  • BPC-157 10 mg + TB-500 20 mg recovery kit
  • Professional research kit: multiple vials of each peptide

5. Example Reconstitution Chart

Example mixing protocols commonly used in research contexts:

BPC-157
5 mg vial + 2 mL bacteriostatic water = 2.5 mg/mL

TB-500
10 mg vial + 2 mL bacteriostatic water = 5 mg/mL

These concentrations are frequently used in research environments because they allow precise measurement using insulin syringes.

6. Label Information for Vials

• Peptide name (BPC-157 or TB-500)
  • Total mg per vial
  • Lot / batch number
  • Manufacturing date
  • Storage instructions (2–8°C recommended)
  • Research use only disclaimer

7. Market Positioning

The Wolverine Stack is commonly positioned in the recovery and regenerative peptide category.

It is frequently marketed for research related to:

• Injury recovery
  • Athletic recovery models
  • Joint and tendon repair research
  • Connective tissue regeneration studies

8. Example Research Stack Extensions

• Wolverine Stack + CJC-1295 / Ipamorelin
  • Wolverine Stack + BPC-157 oral capsules
  • Wolverine Stack + Thymosin Alpha-1
  • Wolverine Stack + IGF-1 related research compounds

9. Safety and Regulatory Notes

BPC-157 and TB-500 are not approved by the FDA for medical treatment and are commonly distributed as research compounds.

This document is intended for informational and research product description purposes only.